388 related articles for article (PubMed ID: 25460340)
1. Simulation study for evaluating the performance of response-adaptive randomization.
Du Y; Wang X; Jack Lee J
Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
[TBL] [Abstract][Full Text] [Related]
2. Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomization.
Du Y; Cook JD; Lee JJ
J Biopharm Stat; 2018; 28(2):309-319. PubMed ID: 28323532
[TBL] [Abstract][Full Text] [Related]
3. Bayesian response adaptive randomization using longitudinal outcomes.
Hatayama T; Morita S; Sakamaki K
Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
[TBL] [Abstract][Full Text] [Related]
4. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
Thall P; Fox P; Wathen J
Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
[TBL] [Abstract][Full Text] [Related]
5. Block response-adaptive randomization in clinical trials with binary endpoints.
Magirr D
Pharm Stat; 2011; 10(4):341-6. PubMed ID: 22328326
[TBL] [Abstract][Full Text] [Related]
6. Frequentist operating characteristics of Bayesian optimal designs via simulation.
Zhang Y; Trippa L; Parmigiani G
Stat Med; 2019 Sep; 38(21):4026-4039. PubMed ID: 31215685
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
Yu Q; Zhu L; Zhu H
Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
[TBL] [Abstract][Full Text] [Related]
8. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
Wathen JK; Thall PF
Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
[TBL] [Abstract][Full Text] [Related]
9. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
Proper J; Connett J; Murray T
Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
[TBL] [Abstract][Full Text] [Related]
10. The Performance of Fixed-Horizon, Look-Ahead Procedures Compared to Backward Induction in Bayesian Adaptive-Randomization Decision-Theoretic Clinical Trial Design.
Lipsky AM; Lewis RJ
Int J Biostat; 2019 Feb; 15(1):. PubMed ID: 30726189
[TBL] [Abstract][Full Text] [Related]
11. Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.
Zhou X; Liu S; Kim ES; Herbst RS; Lee JJ
Clin Trials; 2008; 5(3):181-93. PubMed ID: 18559407
[TBL] [Abstract][Full Text] [Related]
12. Bayesian adaptive randomization designs for targeted agent development.
Lee JJ; Xuemin Gu ; Suyu Liu
Clin Trials; 2010 Oct; 7(5):584-96. PubMed ID: 20571130
[TBL] [Abstract][Full Text] [Related]
13. A group sequential, response-adaptive design for randomized clinical trials.
Karrison TG; Huo D; Chappell R
Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
[TBL] [Abstract][Full Text] [Related]
14. Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint.
Jiang Y; Zhao W; Durkalski-Mauldin V
Contemp Clin Trials; 2017 Nov; 62():114-120. PubMed ID: 28866294
[TBL] [Abstract][Full Text] [Related]
15. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
Meinzer C; Martin R; Suarez JI
Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
[TBL] [Abstract][Full Text] [Related]
16. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
Zhu H
J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian decision-theoretic sequential response-adaptive randomization design.
Jiang F; Jack Lee J; Müller P
Stat Med; 2013 May; 32(12):1975-94. PubMed ID: 23315678
[TBL] [Abstract][Full Text] [Related]
18. A hybrid Bayesian adaptive design for dose response trials.
Chang M; Chow SC
J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
[TBL] [Abstract][Full Text] [Related]
19. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
Lin J; Bunn V
Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian response-adaptive trial in tuberculosis: The endTB trial.
Cellamare M; Ventz S; Baudin E; Mitnick CD; Trippa L
Clin Trials; 2017 Feb; 14(1):17-28. PubMed ID: 27559021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
